Longevity is moving beyond the domain of medical research to become a potential source of economic and strategic power. Advances in genomics, regenerative medicine, cellular reprogramming, and AI-enabled drug discovery are attracting growing private investment and government attention, even as evidence for dramatic extensions of healthy human lifespan remains limited. Against a backdrop of population ageing and declining fertility, even incremental improvements in healthspan could reshape labour markets, pension systems, healthcare demand, and national productivity.

 

However, longer healthy lives present a fundamental paradox. While they could expand individual freedom, preserve human capital, and create opportunities for education, creativity, and multiple careers, they could also extend working lives at the expense of personal choice, delay inheritance, compound wealth, and allow political, corporate, and scientific elites to retain influence for longer. If access to longevity interventions remains concentrated among wealthier individuals, existing inequalities could deepen across both generations and societies.

 

The geopolitical implications are equally significant. The United States, China, Saudi Arabia, the United Arab Emirates, and Singapore represent different approaches to building longevity research, investment, regulatory, and biotechnology capabilities. Countries that develop and deploy effective interventions could strengthen their human capital and technological competitiveness, while those lacking research infrastructure or access to advanced therapies risk greater dependence on external suppliers. The convergence of AI and biotechnology adds further concerns surrounding biological data, dual-use capabilities, cybersecurity, and the concentration of technological power.

 

This Special Edition identifies the signals that could indicate a transition from scientific promise to systemic change, outlines plausible future scenarios, and examines how governments can prepare. Its central argument is that the strategic consequences of longevity will depend not only on scientific progress, but also on how societies distribute additional healthy years, regulate emerging technologies, and adapt the institutions governing work, wealth, retirement, and political authority.

 

Comments

Write a comment

Your email address will not be published. Required fields are marked *